TARDBP and frontotemporal dementia: Another study measured full-length and phosphorylated TDP-43 in plasma in FTD non-mutation carriers compared to a small subgroup of FTD patients with a C9orf72 repeat expansion, GRN mutation carriers, and healthy controls [79].